RBOEX | VBISX | RBOEX / VBISX | |
Total Expense Ratio | 0.59 | 0.15 | 393% |
Annual Report Gross Expense Ratio | 0.62 | 0.15 | 413% |
Fund Existence | 23 years | 32 years | - |
Gain YTD | 5.695 | 1.974 | 288% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 3000 | 8% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 27.2B | 65.5B | 42% |
Annual Yield % from dividends | 3.97 | 3.65 | 109% |
Returns for 1 year | 5.09 | 1.08 | 473% |
Returns for 3 years | 15.50 | 5.66 | 274% |
Returns for 5 years | 2.83 | -4.83 | -58% |
Returns for 10 years | 15.38 | 3.50 | 440% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RWJ | 48.50 | 0.31 | +0.64% |
Invesco S&P SmallCap 600 Revenue ETF | |||
BTRN | 40.32 | 0.07 | +0.16% |
Global X Bitcoin Trend Strategy ETF | |||
RSPF | 77.90 | -0.11 | -0.14% |
Invesco S&P 500® Equal Weight Fincl ETF | |||
EQLT | 30.14 | -0.05 | -0.17% |
iShares MSCI Emerging Mkts Qual Fac ETF | |||
LABD | 34.70 | -1.85 | -5.06% |
Direxion Daily S&P Biotech Bear 3X ETF |